Skip to content
Screener

Bio-Techne TECH Total Revenue

Total Revenue at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$11.99B
Danaher logo
DanaherDHR
$6.27B+5.5%
Bruker logo
BrukerBRKR
$838.5M+5.2%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$150.84M-2.6%
Revvity logo
RevvityRVTY
$711.12M+7.0%
Agilent Technologies logo
Agilent TechnologiesA
$1.84B+10.0%

Segments

By product

See full
Consumables$257.34M-0.2%
Instruments$27.66M+5.9%
Service$21.45M-21.3%
Royalty$4.97M-1.4%

By geography

See full
US$181.92M
CN$24.48M
GB$12.85M

By segment

See full
Protein Sciences$226.15M-0.7%
Diagnostics And Spatial Biology$85.59M-4.1%

Other financials

Income statement

See full
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemQuarter Ended / March 31, 2026Quarter Ended / March 31, 2025Nine Months Ended / March 31, 2026Nine Months Ended / March 31, 2025
Net sales$311,415$316,181$893,847$902,671
Cost of sales103,127101,625306,170311,211
Gross margin208,288214,556587,677591,460
Operating expenses:
Selling, general and administrative109,338151,269339,242391,881
Research and development23,45524,57970,82173,464
Total operating expenses132,793175,848410,063465,345
Operating income75,49538,708177,614126,115

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's total revenue?
Bio-Techne (TECH) reported total revenue of $311.42M in Q1 2026.
How has Bio-Techne's total revenue changed year-over-year?
Bio-Techne's total revenue decreased by 1.5% year-over-year, from $316.18M to $311.42M.
What is the long-term trend for Bio-Techne's total revenue?
Over 3 years (2022 to 2025), Bio-Techne's total revenue has grown at a 3.3% compound annual growth rate (CAGR), from $1.11B to $1.22B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Bio-Techne's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude